Stem Cell Based Diabetes Treatment: Alan Lewis - CIRM Science Writer's Seminar

Alan Lewis, Ph.D., spoke at the Scientific Writer’s Seminar, a workshop presented on September 17, 2008 at CIRM headquarters in San Francisco. At the time of this presentation Alan Lewis was president and CEO of Novocell (now ViaCyte), a La Jolla-based company that has been developing a potential therapy for diabetes. Viacyte Inc. has four CIRM grants to help get a stem cell based therapy for diabetes to the FDA for clinical trials.

Disease Programs

Learn about how stem cell research could generate the therapies for many chronic diseases and injuries

See disease fact sheets

CIRM Stem Cell Blog